M. Gustavson

发表

Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical Trial.

John M S Bartlett, Hein Putter, Cornelis J H van de Velde, 2016, Archives of pathology & laboratory medicine.

Influence of tumor microenvironment on prognosis in colorectal cancer: Tissue architecture-dependent signature of endosialin (TEM-1) and associated proteins

J. Bordeaux, N. Nicolaides, D. O'Shannessy, 2014, Oncotarget.

Tissue microarrays and quantitative tissue-based image analysis as a tool for oncology biomarker and diagnostic development.

M. Dolled-Filhart, M. Gustavson, 2012, Expert opinion on medical diagnostics.

The synovial sarcoma translocation protein SYT-SSX2 recruits β-catenin to the nucleus and associates with it in an active complex

J. E. Eid, M. Gustavson, N. Neel, 2006, Oncogene.

The PEA3 Subfamily of Ets Transcription Factors Synergizes with β-Catenin–LEF-1 To Activate Matrilysin Transcription in Intestinal Tumors

B. Fingleton, L. Matrisian, J. Hassell, 2001, Molecular and Cellular Biology.

RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.

W. Curran, Meihua Wang, D. Brachman, 2013, International journal of radiation oncology, biology, physics.

Tissue microarrays: leaping the gap between research and clinical adoption.

D. Rimm, M. Dolled-Filhart, M. Gustavson, 2013, Personalized medicine.

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

David J. Harrison, Mark Gustavson, D. Harrison, 2011, Journal of visualized experiments : JoVE.

Tcf binding sequence and position determines β‐catenin and Lef‐1 responsiveness of MMP‐7 promoters

Mark D Gustavson, B. Fingleton, L. Matrisian, 2004, Molecular carcinogenesis.

Molecular Analysis of Non–Small Cell Lung Cancer Identifies Subsets with Different Sensitivity to Insulin-like Growth Factor I Receptor Inhibition

Adrian V. Lee, S. McDonald, D. Rimm, 2010, Clinical Cancer Research.

EGFR Protein Expression in Non–Small Cell Lung Cancer Predicts Response to an EGFR Tyrosine Kinase Inhibitor—A Novel Antibody for Immunohistochemistry or AQUA Technology

Cindy Tran, Toshitaka Nagao, Norihiko Ikeda, 2011, Clinical Cancer Research.

Validation of IHC4 algorithms for prediction of risk of recurrence in early breast cancer using both conventional and quantitative IHC approaches

H. Putter, D. Rea, D. Rimm, 2012 .

Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts

L. Harris, D. Rimm, R. Camp, 2011, Breast Cancer Research.

Prognostic significance of FRA expression in epithelial cancers using AQUA(®) technology.

M. Dolled-Filhart, D. O'Shannessy, M. Gustavson, 2013, Biomarkers in medicine.

Standardization of HER2 immunohistochemistry in breast cancer by automated quantitative analysis.

Dylan Reilly, Robert Pinard, Christine Williams, 2009, Archives of pathology & laboratory medicine.

Analytic Variability in Immunohistochemistry Biomarker Studies

K. Syrigos, D. Rimm, J. Giltnane, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Mapping of two mouse membrane-type matrix metalloproteinase (MT-MMP) genes, Mmp15 and Mmp16, to mouse chromosomes 8 and 4, respectively.

S. Apte, M. Gustavson, M. F. Seldin, 1998, Genomics.

Molecular classification of nonsmall cell lung cancer using a 4‐protein quantitative assay

Taxiarchis Botsis, David L Rimm, Dimitrios Dougenis, 2012, Cancer.

Breast Cancer Misclassification: A Major Obstacle to Treatment?

D. Rimm, M. Gustavson, E. Romeo, 2011, Women's health.

Development of an Unsupervised Pixel-based Clustering Algorithm for Compartmentalization of Immunohistochemical Expression Using Automated QUantitative Analysis

Robert Pinard, Christine Williams, Mark D Gustavson, 2009, Applied immunohistochemistry & molecular morphology : AIMM.

Automated analysis of tissue microarrays.

D. Rimm, M. Dolled-Filhart, R. Camp, 2010, Methods in molecular biology.

Abstract PD6-01: Novel approach to HER2 quantification: Digital pathology coupled with AI-based image and data analysis delivers objective and quantitative HER2 expression analysis for enrichment of responders to trastuzumab deruxtecan (T-DXd; DS-8201), specifically in HER2-low patients

J. Barrett, S. Sridhar, H. Sade, 2021 .

Company Profile: HistoRx: tissue-based diagnostic solutions for personalized medicine.

M. Dolled-Filhart, M. Gustavson, E. Romeo, 2012, Personalized medicine.

AQUA analysis of thymidylate synthase reveals localization to be a key prognostic biomarker in 2 large cohorts of colorectal carcinoma.

D. Rimm, R. Camp, A. Molinaro, 2008, Archives of pathology & laboratory medicine.